Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Titre (en) » - entrée « major »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
maintenance < major < make  Facettes :

List of bibliographic references indexed by major

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000129 (2021) Sinosh Skariyachan [Inde] ; Dharshini Gopal [Inde] ; Aditi G. Muddebihalkar [Inde] ; Akshay Uttarkar [Inde] ; Vidya Niranjan [Inde]Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies.
000298 (2021) Marcello Cottini [Italie] ; Carlo Lombardi [Italie] ; Alvise Berti [États-Unis]Obesity is a Major Risk Factor for Hospitalization in Community-Managed COVID-19 Pneumonia.
000B04 (2020) Kelly Servick ; Martin EnserinkThe pandemic's first major research scandal erupts.
000C75 (2020) Silvia Rizzi ; Maarten Jan Wensink ; Rune Lindahl-Jacobsen ; Lu Tian ; Ying Lu ; Michael EisenbergRisk of pre-term births and major birth defects resulting from paternal intake of COVID-19 medications prior to conception.
000C76 (2020) Silvia Rizzi [Danemark] ; Maarten J. Wensink [Danemark] ; Rune Lindahl-Jacobsen [Danemark] ; Lu Tian [États-Unis] ; Ying Lu [États-Unis] ; Michael L. Eisenberg [États-Unis]Risk of pre-term births and major birth defects resulting from paternal intake of COVID-19 medications prior to conception.
000F47 (2020) Sebastiaan Dhont [Belgique] ; Rutger Callens [Belgique] ; Dieter Stevens [Belgique] ; Fre Bauters [Belgique] ; Jan L. De Bleecker [Belgique] ; Eric Derom [Belgique] ; Eva Van Braeckel [Belgique]Myotonic dystrophy type 1 as a major risk factor for severe COVID-19?
000F88 (2020) Kyoji Ito [Japon] ; Norio Ohmagari [Japon] ; Ayako Mikami [Japon] ; Wataru Sugiura [Japon]Major ongoing clinical trials for COVID-19 treatment and studies currently being conducted or scheduled in Japan.
000F89 (2020) Parisa Ghasemiyeh [Iran] ; Afshin Borhani-Haghighi [Iran] ; Iman Karimzadeh [Iran] ; Soliman Mohammadi-Samani [Iran] ; Afsaneh Vazin [Iran] ; Anahid Safari [Iran] ; Adnan I. Qureshi [États-Unis]Major Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review.
001958 (2020) Melanie A. Hundt [États-Unis] ; Yanhong Deng [États-Unis] ; Maria M. Ciarleglio [États-Unis] ; Michael H. Nathanson [États-Unis] ; Joseph K. Lim [États-Unis]Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "major" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "major" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    major
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021